MSK RECALIBRATION LTD

Executive Summary

MSK Recalibration Ltd is a recently established small private company with a sound short-term financial position and full regulatory compliance. Its limited operating history and very small scale pose some risk, but current data indicates low solvency or liquidity concerns. Further diligence should focus on the business model and governance given sole director control and minimal capitalization.

MSK RECALIBRATION LTD - Analysis Report

Company Number: 14761055

Analysis Date: 2025-07-19 12:06 UTC

1. Risk Rating: LOW

Justification: MSK Recalibration Ltd is a newly incorporated small private limited company with a positive net current asset position and no overdue filings. Cash holdings exceed current liabilities, indicating an ability to meet short-term obligations. There are no signs of financial distress or governance issues at this early stage.

2. Key Concerns:

• Limited operating history: Incorporated in March 2023 with only one year of accounts, financial and operational stability is not yet established.
• Very small scale: Only one employee and minimal net assets (£1,976) could constrain growth and resilience to shocks.
• Single shareholder/director control: Full ownership and control by one individual could present governance and succession risks.

3. Positive Indicators:

• Timely filing of accounts and confirmation statement, showing compliance with regulatory requirements.
• Positive net current assets and cash balance above current liabilities, suggesting short-term solvency.
• Clear accounting policies and adherence to small company accounting standards with no audit exemptions issues.

4. Due Diligence Notes:

• Review business plan and cash flow forecasts to assess sustainability and growth prospects.
• Verify nature and amount of any off-balance sheet liabilities or contingent risks not captured in abridged accounts.
• Consider background and experience of sole director/shareholder to evaluate operational capability and governance.
• Monitor future filings for signs of revenue growth, profitability, or capital injections.